Market Place
Sourcing Support
Union Presents Orismilast Ph 2a In Ulcerative Colitis At ECCO 2025
21 Feb 2025 //
PR NEWSWIRE
UNION Announces ADESOS Phase 2b Results For Orismilast
25 Sep 2024 //
PR NEWSWIRE
UNION to present orismilast Phase 2b results in atopic dermatitis
20 Sep 2024 //
PR NEWSWIRE
UNION: ADESOS Phase 2b Success, Data At RAVE Conference 2024
04 Jun 2024 //
PR NEWSWIRE
UNION therapeutics announces presentation of new data on orismilast
06 Oct 2023 //
PR NEWSWIRE
US FDA grants Fast Track status for UNION’s oral orismilast to treat HS
11 Jan 2023 //
PHARMACEUTICAL-TECHNOLOGY
UNION announces positive results from IASOS Phase 2b study of oral orismilast
09 Jan 2023 //
PR NEWSWIRE
Innovent & UNION Announce First Subject Dosed in a Chinese PhI Study Orismilast
04 Dec 2022 //
PRNEWSWIRE
UNION announces regulatory approval of Treatment for ongoing OSIRIS Ph2a
01 Sep 2022 //
CISION
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.